This meeting is the official congress of the Journal of Clinical Pathways and serves as a forum for those involved in all stages of the clinical pathway development process to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway programs.
This activity is designed for directors of oncology practice programs and cancer centers, oncologists, hematologists, commercial and government payers, pathway development executives, reimbursement specialists, specialty pharmacists, HEOR specialists, and other healthcare professionals interested in learning how to implement, integrate, and measure treatment pathways.
The Clinical Pathways Congress conference provides participants with the opportunity to:
- Outline the opportunities and challenges associated with using clinical pathways as a foundation for value-based care
- Examine the roles and responsibilities of payers, providers, and pathway developers in creating and implementing clinical pathways
- Contribute to the effective implementation of clinical pathways to optimize quality of care, cost-efficiency, and health outcomes
- Assess efficacy and safety of current and recently approved agents to incorporate into second-and third-line treatment of HER2-positive breast cancer
- Describe the challenges of creating and implementing clinical pathways for HER2-positive breastcancer
- Develop clinical pathways for HER2-positive breast cancer to optimize evidence-based and cost-effective second-and third-line treatments
- Describe the clinical challenges and unmet needs associated with treatment selection and management of mUC
- Evaluate the safety, efficacy, and cost-effectiveness data associated with available first-, second, and subsequent-line therapies for mUC
- Tailor clinical pathways to incorporate evidence-based and patient-centered care strategies to address treatment selection and sequencing, treatment barriers, adherence, adverse events, and costs
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Credit Designation Statements
This activity was planned by and for the healthcare team, and learners will receive 15.25 Interprofessional Continuing Education (IPCE) credit for learning and change.
This activity has been approved for 15.25 AMA PRA Category 1 Credit™.
This live, knowledge-based activity (Universal Activity Number: JA0006201-0000-23-056-L01-P) has been approved to award 15.25 contact hours (1.52 CEUs).
The certificate is not the official record of your participation in the activity. The official record of credit will be the information in the CPE Monitor system. Following ACPE Policy, HMP Education must transmit your claim to CPE Monitor within 60 days from the date you complete this CPE activity. HMP Education is not able to report your claimed credit after this 60-day period. Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended.
This continuing nursing education live activity awards 15.25 contact hours.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 15.25 contact hours.
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
HMP Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This live activity is designated for 15.25 AAPA Category 1 credits. PAs should claim only credit commensurate with the extent of their participation.
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609.371.1137, by email at firstname.lastname@example.org, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint.
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call (770) 751-7332 / (609) 371-1137.
Non-Accredited Innovation Theaters
These are promotional programs; no CE credits are offered. All attendees, please be advised that information—e.g., your name and the value of any meal you receive during these promotional programs—may be publicly disclosed pursuant to applicable federal and/or state laws. If you are licensed in a state or are an employee of an organization that limits or prohibits meals from pharmaceutical companies, please identify yourself so that everyone is able to comply with such requirements.
Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.